Clinical Trials

A Remote Physical Activity Program in the Population Suffering from Type 1 Myotonic Dystrophy

Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1

Global Study of Del-desiran for the Treatment of DM1

Myotonic Dystrophy - Vascular and Cognition

Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life

DM-IMT - Controlled, Randomized, Three-arm Intervention Study on the Safety and Efficacy of Regular Respiratory Muscle Training in Patients With Myotonic Dystrophy Type 1

Effect of MYODM on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1

Effects of a 12-week Strength Training Program in Men With Myotonic Dystrophy Type 1

Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1

Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)

Low-frequency Repetitive Nerve Stimulation in Myotonic Dystrophy Type 1

Methylphenidate in Myotonic Dystrophy Type 1

Multicenter Observational Study of Myotonic Dystrophy Type 1

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Myotonic Dystrophy Type 1 and Resistance Exercise

NIPD on CFTC for Triplet Repeat Diseases

Profile of Dysphagia in Myotonic Dystrophy Type 1 (DM1)

RAMYD Study - Evaluation of Arrhythmic Risk in Myotonic Dystrophy

Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1

Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1